Sunder Biomedical Tech Co (4115.TWO) Stock Price

Sunder Biomedical Tech Co Price

CLOSED
6.80
​
Market closed

Over the last 24 years Sunder Biomedical Tech Co grew revenue by 7.4% annually, reaching 753.45 M TWD. Earnings per share have grown at 15.9% per year over the last 23 years. For Sunder Biomedical Tech Co, the net margin of -2.2% is down versus 6.2% a few years ago. At today's price the dividend yield works out to roughly 4.41%.

Sunder Biomedical Tech Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunder Biomedical Tech Co business model & stock analysis

Sunder Biomedical Tech Co Ltd manufactures and sells medical consumables including blood circuit catheters, puncture needles, infusion sets, suction tubing, dosing sets, waste fluid collection bags, and protective covers. The company also produces laparoscopic smoke filters, suction sets, pick-up bags, and medical grade materials such as PVC pellets, NON-diethylhexyl phthalate (DEHP) PVC, and other medical components. Additionally, Sunder Biomedical offers sterilization and laboratory services, along with foundry services for masks, tubes, and nucleic acid extraction well tray consumables. The primary buyers of Sunder Biomedical's products are healthcare facilities, hospitals, and medical institutions requiring disposable medical equipment and supplies. These clients purchase medical consumables for routine procedures, surgical operations, and patient care. The company's focus on medical grade materials ensures compliance with healthcare standards, making its products essential for medical professionals. Sunder Biomedical's revenue streams include direct sales of medical consumables, sterilization services, and foundry services for specialized medical components. The company targets the healthcare sector, particularly hospitals and clinics, where demand for reliable, high-quality disposable medical products is consistent. By providing a comprehensive range of medical supplies, Sunder Biomedical caters to the operational needs of healthcare providers across various medical specialties.

Frequently asked questions about Sunder Biomedical Tech Co

Converted at the current exchange rate, the Sunder Biomedical Tech Co share trades at 0.19 EUR (6.80 TWD).

The revenue cannot currently be calculated for Sunder Biomedical Tech Co.

The profit cannot currently be calculated for Sunder Biomedical Tech Co.

The P/E ratio cannot be calculated for Sunder Biomedical Tech Co at the moment.

The P/S cannot be calculated for Sunder Biomedical Tech Co currently.

The Eulerpool Quality Score for Sunder Biomedical Tech Co is 3/10.

The ISIN of Sunder Biomedical Tech Co is TW0004115001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Sunder Biomedical Tech Co is 4115.TWO. The ticker symbol is used to trade Sunder Biomedical Tech Co shares on the stock exchange.

Fair ValueTerminal
5.58 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Aug 31, 2022
ISIN
TW0004115001
Cusip
Y8213B138
Market capitalization
408.00 M TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.54
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.83 %
Dividend
Dividend yield
0.00 %
Payout Ratio
0.00 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Nov 22, 2026, 3:48 AM

Sunder Biomedical Tech Co Peer Group

Sunder Biomedical Tech Co FIGI

4115:TT (Taipei Stock Exchange) · BBG019BR4547